Brefel-Courbon C - Search Results

1

Challenging diagnosis and treatment decision of a long-history autoantibody-negative autoimmune encephalitis.

Calvat P, Leung C, Bost C, Fortenfant F, Simonetta-Moreau M, Pariente J, Rafiq M, Brefel-Courbon C, Rascol O, Fabbri M, Ory-Magne F. Calvat P, et al. Parkinsonism Relat Disord. 2023 Feb;107:105232. doi: 10.1016/j.parkreldis.2022.105232. Epub 2022 Dec 7. Parkinsonism Relat Disord. 2023. PMID: 36509623 No abstract available.

2

[ What drug strategies are advisable for patients with advanced-stage Parkinson's].

Brefel-Courbon C. Brefel-Courbon C. Rev Neurol (Paris). 2000;156 Suppl 2 Pt 2:120-59. Rev Neurol (Paris). 2000. PMID: 10916046 Review. French. No abstract available.

3

Comparison of chronic analgesic drugs prevalence in Parkinson's disease, other chronic diseases and the general population.

Brefel-Courbon C, Grolleau S, Thalamas C, Bourrel R, Allaria-Lapierre V, Loï R, Micallef-Roll J, Lapeyre-Mestre M. Brefel-Courbon C, et al. Pain. 2009 Jan;141(1-2):14-8. doi: 10.1016/j.pain.2008.04.026. Epub 2008 Dec 4. Pain. 2009. PMID: 19062167

4

Alpha-synuclein gene rearrangements in dominantly inherited parkinsonism: frequency, phenotype, and mechanisms.

Ibáñez P, Lesage S, Janin S, Lohmann E, Durif F, Destée A, Bonnet AM, Brefel-Courbon C, Heath S, Zelenika D, Agid Y, Dürr A, Brice A; French Parkinson's Disease Genetics Study Group. Ibáñez P, et al. Arch Neurol. 2009 Jan;66(1):102-8. doi: 10.1001/archneurol.2008.555. Arch Neurol. 2009. PMID: 19139307

5

Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effects.

Periquet M, Lücking C, Vaughan J, Bonifati V, Dürr A, De Michele G, Horstink M, Farrer M, Illarioshkin SN, Pollak P, Borg M, Brefel-Courbon C, Denefle P, Meco G, Gasser T, Breteler MM, Wood N, Agid Y, Brice A; French Parkinson's Disease Genetics Study Group. The European Consortium on Genetic Susceptibility in Parkinson's Disease. Periquet M, et al. Am J Hum Genet. 2001 Mar;68(3):617-26. doi: 10.1086/318791. Epub 2001 Feb 14. Am J Hum Genet. 2001. PMID: 11179010 Free PMC article.

6

[Prevalence of diabetes in france and drug use: study based on the French pharmacovigilance database].

Berthet S, Grolleau S, Brefel-Courbon C, Montastruc JL, Lapeyre-Mestre M. Berthet S, et al. Therapie. 2007 Nov-Dec;62(6):483-8. doi: 10.2515/therapie:2007076. Epub 2008 Mar 4. Therapie. 2007. PMID: 18316014 French.

7

Identification of VPS35 mutations replicated in French families with Parkinson disease.

Lesage S, Condroyer C, Klebe S, Honoré A, Tison F, Brefel-Courbon C, Dürr A, Brice A; French Parkinson's Disease Genetics Study Group. Lesage S, et al. Neurology. 2012 May 1;78(18):1449-50. doi: 10.1212/WNL.0b013e318253d5f2. Epub 2012 Apr 18. Neurology. 2012. PMID: 22517097 No abstract available.

8

[Digestive disturbances in Parkinson disease].

Brefel-Courbon C. Brefel-Courbon C. Rev Neurol (Paris). 2009 Apr;165 Spec No 2:F63-5. Rev Neurol (Paris). 2009. PMID: 19593862 Review. French. No abstract available.

9

Drug-induced myoclonus: a French pharmacovigilance database study.

Brefel-Courbon C, Gardette V, Ory F, Montastruc JL. Brefel-Courbon C, et al. Neurophysiol Clin. 2006 Sep-Dec;36(5-6):333-6. doi: 10.1016/j.neucli.2006.12.003. Epub 2007 Jan 25. Neurophysiol Clin. 2006. PMID: 17336778 Review.

10

[Parkinson disease and the noradrenaline system].

Brefel-Courbon C. Brefel-Courbon C. Presse Med. 2002 Aug 10;31(26):1240-2. Presse Med. 2002. PMID: 12212518 French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters